Zugriffe | |
---|---|
Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 242 |
Oktober 2023 | November 2023 | Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 3 | 7 | 5 | 11 | 4 | 2 | 5 |
Zugriffe | |
---|---|
3_Chapter3_Materials_Methods.pdf | 180 |
6_Chapter6_References.pdf | 179 |
1_Chapter1_Introduction_aims_objectives.pdf | 166 |
7_Chapter7_Appendices_Aknowledgements.pdf | 141 |
0_Title_Index.pdf | 120 |
2_Chapter2_Literature_review.pdf | 83 |
4_Chapter4_Results_Discussions.pdf | 82 |
5_Chapter5_Summary_Zusammenfassung.pdf | 59 |